Back to Search
Start Over
Rôle de la radiothérapie ablative des métastases chez les patients atteints de cancer de la prostate oligométastatique hormonosensible : un essai du Groupe d’étude des tumeurs urogénitales et de l’Association française d’urologie
- Source :
- Cancer/Radiothérapie. 21:491-494
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
-
Abstract
- The goal of treatment of metastatic prostate cancer remains palliation. The oligometastatic state could be the right time to intensify therapy by introducing metastases directed treatments. The aim of this trial was to evaluate the benefit of radiotherapy to all macroscopic metastatic sites and to the primary disease in patients with hormone sensitive oligometastatic prostate cancer.
- Subjects :
- Gynecology
Oncology
medicine.medical_specialty
business.industry
medicine.medical_treatment
medicine.disease
Primary disease
Hormone-sensitive
Radiation therapy
03 medical and health sciences
Prostate cancer
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
medicine
Radiology, Nuclear Medicine and imaging
In patient
030212 general & internal medicine
business
Subjects
Details
- ISSN :
- 12783218
- Volume :
- 21
- Database :
- OpenAIRE
- Journal :
- Cancer/Radiothérapie
- Accession number :
- edsair.doi...........346565cb01a8a0f100c711a2b4bdc52c